Comparison of a One- versus Two-Week Treatment with Famciclovir Upon Reductions in Pain and Occurrence of Postherpetic Neuralgia in Herpes Zoster: A Randomized Open-Label Trial.
PAPERS | February 4-10, 2023 | |
Source: Infect Drug Resist 2023; 16. doi: 10.2147/IDR.S385442Authors: Peng F, He H, Xia T, Lv S
Herpes zoster (HZ) is an acute herpetic skin disease resulting from the varicella-zoster virus. Typically, this condition is treated with a one-week administration of antiviral drugs, including famciclovir, which can effectively control the symptoms during the acute phase and prevent the occurrence of postherpetic neuralgia (PHN).
Pubmed ID: https://pubmed.ncbi.nlm.nih.gov/36756610/